folder Filed in Funding daily
Mammoth Biosciences reached a Unicorn status following a $150 million investment round
By Tsani Gramatikova access_time 1 min read

What is Mammoth Biosciences?

Mammoth Biosciences is a CRISPR application.

What does Mammoth Biosciences do?

The company is developing CRISPR applications for disease detection, research, agriculture, biodefense, and more.

Who owns Mammoth Biosciences?

Ashley Tehranchi, Janice Chen, Jennifer Doudna, Lucas Harrington, and Trevor Martin founded the company in 2017 in San Francisco Bay Area.

How much has Mammoth Biosciences raised?

The company announced that it raised $150 million in a Series D financing round, reaching a valuation of more than $1 billion and reaching a Unicorn status.

Who has invested in Mammoth Biosciences?

Plum Alley Investments and Decheng Capital are the most recent investors.

What domain name does Mammoth Biosciences operate on?

Mammoth Biosciences is operating on the domain name.

Mammoth Biosciences is a CRISPR application.

Other resources

How does your brand name match your company vision? What new horizons can a better name open? Get in touch if you feel your brand deserves a better name, we are always happy to help.

branding business domain domains funding naming